What is C2DX?
Founded in 2019, C2DX operates within the medical device sector, focusing on the strategic acquisition and enhancement of specialized products. The company's mission is to broaden the accessibility of valuable medical technologies globally, ensuring healthcare providers are equipped with essential devices and advanced technology. C2Dx's commitment extends to delivering superior customer service, positioning it as a key player in its market segment.
How much funding has C2DX raised?
C2DX has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in C2DX
PPP
Public-Private Partnership
What's next for C2DX?
The substantial late-stage funding indicates C2DX is poised for significant expansion and market penetration. This capital infusion is expected to fuel further refinement of its product delivery systems and accelerate the growth of its niche offerings. The company's strategic focus on evolving healthcare needs suggests a trajectory aimed at solidifying its market position and potentially exploring new product verticals or geographical markets.
See full C2DX company page